Apoptotic cell transfer has been found to be able to facilitate engraftment of allograft. However, the underlying mechanisms remain to be fully understood. Here we demonstrate that intravenous administration of donor apoptotic splenocytes can promote pancreatic islet engraftment by inducing generation of tolerogenic dendritic cells (Tol-DCs) and expansion of CD4 
INTRODUCTION
Most of the immunosuppressive agents we use today are nonspecific and their immunosuppressive effects on chronic allograft rejection need to be further improved. Long-term administration of immunosuppressant may also lead to infection or cancer. 1, 2 So, induction of long-term donor-specific immune tolerance is the best way for prevention of graft rejection. Cells that undergo apoptosis rarely cause autoimmunity for the following reasons. First, apoptotic cells are captured quickly by phagocytes such as macrophages and dendritic cells (DCs). 3 Secondly, apoptotic cells can promote the release of IL-10 and transforming growth factor-b (TGF-b) from monocytes and inhibit the release of tumor-necrosis factor-a (TNF-a), IL-1b and IL-12. 4 Apoptotic cells may also release IL-10 and TGF-b themselves. 5 Immunosuppressive function of apoptotic cells has been confirmed in many model systems. [6] [7] [8] Within the context of transplantation, transfusion with donor apoptotic splenocytes prolongs allograft survival. 9 Previous studies have revealed a critical role of inducible regulatory T cells (Tregs) in immune tolerance induced by apoptotic cells. 8 However, the detailed mechanisms for the induction of Tregs or other kind of immunosuppressive cells by apoptotic cells remain poorly understood.
Tregs play a critical role in maintaining immunological unresponsiveness to self-antigens and in suppressing excessive immune responses detrimental to the host. 10 Tregs were first identified as a suppressive T-cell subset expressing IL-2 receptor a chains (CD25). 11 The transcriptional factor Foxp3 (forkhead box protein 3) is a dominant regulator of Treg development and function. 12 Specifically, Foxp3 transduction in naive T cells upregulates the expression of CD25 and other Tregs associated cell-surface molecules, such as cytotoxic T cell-associated antigen-4 and glucocorticoid-induced TNF receptor family-related gene/protein, and represses the production of IL-2, IFN-c and IL-4. 13 Tregs could directly eliminate responder T cells via a granzyme/perforin dependent mechanism, or indirectly by inducing apoptosis through absorption of cytokines.
14 Several studies have suggested that IL-10 and TGF-b secreting by Tregs may also contribute to their immunosuppressive activity. 15, 16 However, the mechanisms for the immunosuppressive effect of Tregs need to be further investigated.
DCs are professional antigen-presenting cells of multiple lineages and have the potential to induce both immunity and tolerance. [17] [18] [19] Tolerogenic DCs (Tol-DCs) are immature, maturation-resistant or alternatively activated DCs that express low levels of surface MHC and costimulatory molecules. Many strategies have been used to expand Tol-DCs. For example, Tol-DCs can be derived by genetic manipulation that enhances the expression of T cell-associated antigen-4, indoleamine 2,3-dioxygenase, CD95L, IL-10 or TGF-b. [20] [21] [22] We also show that soluble TNF-a receptor gene-modified immature DCs can prolong allograft survival more significantly than immature DCs used alone, indicating soluble TNF-a receptor gene-modified DCs exhibit more tolerogenicity. 23 Bone marrow-derived DCs (BMDCs) could also be rendered tolerogenic in the presence of IL-10, TGF-b and vascular endothelia growth factor or immunosuppressive drugs. [24] [25] [26] Tol-DCs can induce alloantigen specific T cell anergy and drive de novo differentiation of Tregs from naive T cells. [27] [28] [29] [30] [31] Recent studies show that Tol-DCs can also induce anergy and regulatory properties in tolerance-resistant memory CD4
1 T cell and dampen memory T-cell response. 32 Repetitive intravenous administration of Tol-DCs has been shown to prolong cardiac allograft survival in mice. 33 Tregs could aggregate around DCs, 34 and compete with naïve T cells for interaction with DCs. 35, 36 Whether the reciprocal induction and functional interaction of Tol-DCs and Tregs contribute to the tolerance induction by apoptotic cells needs to be further explored.
In this study, we demonstrated that reciprocal interaction between Tol-DCs and Tregs is essential for the induction of immune tolerance by in vivo infusion with apoptotic cells, which contribute to promote pancreatic islet engraftment by apoptotic cell transfer. In the immune tolerance induced by apoptotic cell administration, Tol-DCs promote the expansion of Tregs via programmed death 1 ligand (PD-L1) on their surface, and Tregs facilitate Tol-DCs to sustain tolerogenic state via IL-10 and TGF-b.
MATERIALS AND METHODS

Mice and reagents
Female BALB/c and C57BL/6 mice (6-8 weeks) were purchased from SIPPER BK Experimental Animals Co. (Shanghai, China). CD11c-DTR mice, Smad3-deficient (Smad3 2/2 ) mice and IL-10-deficient (IL-10 2/2 ) mice were bred and maintained in a specific pathogen free facility. 37, 38 All animal experiments were undertaken in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals, with the approval of the Scientific Investigation Board of Second Military Medical University, Shanghai, China. Collagenase V, streptozocin (STZ), dithizone, diphtheria toxin (DT), lipopolysaccharide (LPS; Escherichia coli, O26:B6), annexin V-FITC and propidium iodide (PI) were all purchased from SigmaAldrich (St Louis, MO, USA). Recombinant mouse granulocytemacrophage colony-stimulating factor and IL-4 were from PeproTech (London, UK). Anti-CD3e (145-2C11), anti-CD16/ 32, anti-PD-L1 (10F.9G2), antiPD-L2 (TY25) and isotype control antibodies were from BioLegend (San Diego, CA, USA). Anti-CD25 antibody (PC61) was purified in this laboratory. (39-10-8) , PE-Ia b (AF6-120.1) and PE-PD-L1 (10F.9G2) were from BD Pharmingen (San Diego, CA, USA). PE-Foxp3 was from eBioscience (San Diego, CA, USA). CD11c monoclonal antibody (mAb) microbeads and Treg isolation kit were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany).
Cell preparation
Signal cell suspensions were obtained by homogenizing spleens. Spleenocytes were resuspended in phosphate-buffered saline (PBS) after dissolving erythrocytes in ammonium chloride solution. Apoptotic splenocytes were obtained as previously described. 39 Briefly, splenocytes ( 5310 6 ) were suspended in 5 ml PBS in a 10-cm-diameter Petri plate and exposed to a 40 W UV (320 nm) source at a distance of 40 cm for 10 min. After irradiation, splenocytes were resuspended in RPMI-1640 (with 10% fetal bovine serum) and cultured for 4 h before infusion. Splenic CD11c 1 DCs were labeled by CD11c mAb microbeads and isolated with MACS. Tregs were isolated using a CD4 1 CD25 1 Regulatory T Cell Isolation Kit. Briefly, non-CD4 1 T cells were removed. The remaining cells were labeled with anti-CD25 microbeads for magnetic separation. Purity of enriched CD4
1 CD25 1 T cell fraction was .90% as confirmed by FACS. Apoptotic donor splenocytes were induced by UVB irradiation and verified by annexin V-FITC and PI staining. 40 Generation of bone marrow-derived DCs BMDCs were generated as previously described. 41 Briefly, bone marrow progenitors were cultured for 48 h in RPMI-1640 supplemented with 10% fetal bovine serum, 10 ng/ml murine granulocyte-macrophage colony-stimulating factor and 1 ng/ ml IL-4. Nonadherent cells were gently removed; the remaining loosely adherent clusters were cultured for an additional 3 days Apoptotic donor cells induce immune tolerance C Wu et al prior to the harvest. Mature BMDCs were generated from immature BMDCs by stimulation with 10 ng/ml LPS for 1 day.
Islet isolation and transplantation
Islets were isolated from C57BL/6(H-2 b ) mice as previously described with some modifications (BALB/c mice were used as donors while CD11c-DTR mice act as recipients). 42 Briefly, the pancreatic duct was distended with collagenase V and purified on an OptiPrep gradient (AXIS-SHIELD, Dundee, Scotland). Islets with diameters between 75 and 250 mm were hand-picked and transplanted under the renal capsule of STZ induced diabetic BALB/c (H-2 d ) mice (non-fasting blood glucose .20 mmol/l on 3 consecutive days). Each recipient received 200-250 islets. Apoptotic donor splenocytes (10 7 cells) were infused to recipient mice via tail vein 1 week prior to islet transplantation. Blood glucose ,10 mmol/l after transplantation was considered engraftment, and .20 mmol/l was considered islet graft rejection. In some experiments, mice received intraperitoneal injection of DT (16 ng/g), PC61 (500 mg) or anti-PD-L1 antibody (100 mg) at 24 h prior to infusion with apoptotic cells. 43 Cytokines in the supernatant were assayed by enzyme-linked immunosorbent assay kit (R&D Systems, Minnesota, MN, USA).
Mixed-lymphocyte reaction and in vitro suppression assay
In vitro conversion assay For the Tregs conversion assay, CD4
1 CD25 2 T (5310 4 ) cells isolated from BALB/c mice were cultured with splenic DCs (5310 4 ) purified from tolerant mice or syngeneic BALB/c mice for 3 days in the presence of 100 ng/ml anti-CD3e mAb. In some experiments, antibody against PD-L1 or PD-L2 (0.5 mg/ ml for both) was included. Foxp3 expression was detected by FACS analysis. For the tolerogenic DCs conversion assay, imDCs (1310 5 ) from BALB/c mice were cultured with Tregs or CD4 1 CD25 2 T cells ( 1310 5 ) isolated from tolerant mice or a mixture of these two populations at 1 : 1 ration for 3 days. The phenotype of DCs was analyzed by FACS Callibur. Cytokines in the supernatant were assayed by enzyme-linked immunosorbent assay.
Flow cytometry
The phenotypes of splenocytes, isolated/cultured DCs and T cells were analyzed by FACSCallibur with CELLQUEST software (BD Biosciences). For intracellular analysis of Foxp3 expression, cells were stained with PE-Foxp3 according to the manufacturer's protocol (eBioscience). All experiments were carried out with appropriate isotype control as described previously. 23 
Statistical analysis
Data are shown as means6s.d. The Wilcoxon rank sum test was conducted in the two group comparisons. Graft survival was compared among experimental groups using the KaplanMeier test. The statistical significance is satisfied at P,0.05 level.
RESULTS
Infusion of apoptotic cells prolongs islets allograft survival
The apoptosis induction of splenocytes was detected by AnnexinV and PI stain. More than 60% of the splenocytes were rendered apoptotic by 4 h after irradiation (Figure 1a ). Islets were purified from C57BL/6 mice and visualized by optical microscopy (Figure 1b) , and then transplanted into the diabetic BALB/c mice which were prepared by i.p. injected of STZ. The graft survival (blood glucose ,10 mmol/l) was enhanced significantly in the recipient mice with apoptotic cell preinfusion than that in recipients without apoptotic cell preinfusion (56.961.8 days versus 7.660.8 days, n510, P,0.01) (Figure 1c ). Pre-infusion with live splenocytes from donor mice could not enhance engraftments in recipients (Figure 1c ). Grafts in PBS-treated recipients have heavier infiltration of lymphocytes than that in recipients with pre-infusion of apoptotic splenocytes treated as shown in histological analysis (Figure 1d ). Transfusion with apoptotic cells derived from donor C57BL/6 mice prior to islet transplantation resulted in relatively low and stable blood glucose during the entire experiment period (Figure 1e ). Also, we observed that infusion with apoptotic cells alone did not affect blood glucose level in the diabetic mice (data not shown). Therefore, pre-infusion with donor apoptotic cells can significantly promote the islets engraftment in recipient mice.
Induction of Tregs and tolerogenic DCs in vivo by apoptotic cell infusion
In comparison to the age-matched diabetic BALB/c mice receiving no treatment (neither apoptotic cell infusion nor transplantation), diabetic mice receiving apoptotic cell transfusion prior to islet transplantation and with the engraftment surviving .60 days (referred to as 'tolerant mice' below) had increased CD4
1 Foxp3 1 Tregs (6.260.8% versus 3.160.4%, P,0.05) and CD4 1 CD25 1 T cells (7.560.6% versus 3.360.4%, P,0.05) in the splenocytes (Figure 2a ). Surface expression of MHC class II molecule, CD80, CD86 and CD40 was downregulated, but the expression of PD-L1 was upregulated on splenic DCs in tolerant mice (Figure 2b ). This indicated that DCs from tolerant mice are Tol-DCs. In comparison to the age-matched control diabetic mice receiving no treatment, Tregs isolated from tolerant mice had stronger inhibitory effect in a mixed-lymphocyte reaction (MLR) assay that included donor (C57BL/6) DCs as stimulators and recipient (BALB/c) T cells as responders (Figure 2c and d). Tregs from tolerant mice could not inhibit MLR between third party (C3H mice) stimulators and BALB/c responders ( Figure 2e ). These findings suggest that apoptotic cell transfusion could induce generation of Tol-DCs and donor-specific Tregs in the recipients.
Depletion of recipients DCs or Tregs in vivo abrogates tolerance induction by apoptotic cell infusion
The experiments procedures are shown as indicated (Figure 3a) . DT and PC61 administrations, which were done 24 h before apoptotic cell infusion, caused DCs and Tregs to be eliminated separately within 24 h and the depletion could sustain for 2-3 days as observed in our study and previous researches. 44, 45 The beneficial effect of apoptotic cell infusion prior to islet transplantation on grafts survival was abrogated by depletion of Tregs with PC61 in diabetic recipients or CD11c 1 DCs with DT in diabetic CD11c-DTR recipients (Figure 3b and c) . recipient DCs and Tregs are important for the immune tolerance induced by apoptotic cell infusion.
Mutual interaction between Tregs and tolerogenic DCs in the induction of immune tolerance by apoptotic cell administration
In the Tol-DCs and anti-CD3e mAb-activated CD4 1 CD25 2 Tcell coculture experiment, Tol-DCs could induce the generation of Foxp3 1 Tregs (Figure 4a ). The conversion induced by Tol-DCs was 15.3%60.8% while the conversion induced by DCs from age matched control diabetic BALB/c mice receiving no treatment was 1.4%60.6% (P,0.05) (Figure 4a Apoptotic splenocytes consist of apoptotic T cells, B cells, apoptotic DCs and many other cell types. Different cells secret different cytokines and act on different molecular targets. 3, 48 We speculate that other apoptotic cells in the spleen might also contribute to Tol-DCs induction. Specific role of each component of apoptotic splenocytes needs to be evaluated. Also, whether mixed apoptotic splenocytes could produce synergistic action is an issue of importance.
Results from the current study demonstrated that the PD-L1 pathway is necessary for Tregs expansion induced by DCs. 49 TolDCs failed to induce Foxp3 expression when separated physically from CD4
1 T cells, indicating that Tregs induction require cellcell contact with Tol-DCs. PD-1 is a member of the CD28 and T cell-associated antigen-4 immunoglobulin superfamily and interacts with PD-L1 (CD274) and PD-L2 (CD273). PD-L1 is widely distributed on leukocytes and non-hematopoietic cells, whereas PD-L2 is expressed exclusively on DCs and monocytes. 50 Our results indicated that Tregs expansion induced by Tol-DCs depend on surface expression of PD-L1. Blockade of the PD-L2, in contrast, did not affect Tregs expansion. A recent study suggested that PD-1-PD-L1 interaction could induce T cell anergy by preventing the conjugation of DCs to T cells; and blockade of PD-L1 promotes prolonged T cell-DC interactions and T-cell activation. 51 Accordingly, T cells could not aggregate around Tol-DCs that express high level of PD-L1 permanently, but separate Tol-DCs and T cells will abrogate Tol-DCs induced Foxp3 expression. So within this context, we speculate that Tregs induction requires low levels of MHC molecules and costimulatory factors. We also speculate that repeated brief conjugation with Tol-DCs might be more conductive for Tregs induction. Alternatively, PD-1/PD-L1 pathway could induce Foxp3 expression; but further experiments are required to address this question in the future.
A previously study showed that Tregs were more mobile than naïve T cells and could aggregate around DCs and inhibit their maturation. 34 Consistent with previous studies of BMDCs, 24, 25, 52, 53 we demonstrated that Tregs producing IL-10 and TGF-b are needed for the maintenance of Tol-DCs. TGF-b and IL-10 could also be produced by apoptotic cells as well as Tol-DCs themselves. 5, 20 Our findings suggest that Tregs secreting TGF-b and IL-10 might be more important in the maintenance rather than the induction of Tol-DCs. Depletion of the Tregs or DCs was temporary in the current study, but was sufficient to prevent tolerance induction. Apoptotic cells were administered once before transplantation but could induce long time tolerance, suggesting that once initiated, the feedback nature of the Treg-Tol-DCs interaction becomes self-sustaining and sufficient for the development of immune tolerance.
In conclusion, in the current study we demonstrate that transfusion with apoptotic splenocytes prior to pancreatic islet transplantation could significantly prolong the survival of islet engraftment by inducing generation of Tol-DCs and 2/2 mice and IL-10 2/2 mice. There is no phenotype changes observed after apoptotic cell administration. Syngenic mice without apoptotic cell administration were used as control (dashed line). Data are based on three independent experiments. DC, dendritic cell; mAb, monoclonal antibody; PD-L1, programmed death 1 ligand; TGF, transforming growth factor; Tol-DC, tolerogenic dendritic cell; Treg, T regulatory cell.
